Section R429-2-2 - Definitions(1) "Adverse drug event" means any event involving a medication that causes or leads to patient harm while the medication is in the control of the facility. Such events may be related to professional practice, health care products, procedures, and systems, including: prescribing, order communication, product labeling, packaging and nomenclature, compounding, dispensing, distribution, administration, education, monitoring, and use.(2) "Department" means the Utah Department of Health;(3) "Facility" means a general acute hospital, critical access hospital, ambulatory surgical center, psychiatric hospital, orthopedic hospital, rehabilitation hospital, chemical dependency or substance abuse hospital or chronic disease hospital as those terms are defined in Title 26, Chapter 25, Part 1, General Provisions.(4) "Harm" means death or temporary or permanent impairment of body function or structure requiring intervention such as:(a) a change in monitoring the patient's condition;(b) a change in therapy; or(c) active medical or surgical treatment.Utah Admin. Code R429-2-2
Adopted by Utah State Bulletin Number 2021-17, effective 8/18/2021